- Home
- GILT vs RNAC Comparison
GILT vs RNAC Comparison
Compare GILT & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILT
- RNAC
- Stock Information
- Founded
- GILT 1987
- RNAC 2007
- Country
- GILT Israel
- RNAC United States
- Employees
- GILT N/A
- RNAC N/A
- Industry
- GILT Radio And Television Broadcasting And Communications Equipment
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- GILT Technology
- RNAC Health Care
- Exchange
- GILT Nasdaq
- RNAC Nasdaq
- Market Cap
- GILT 400.3M
- RNAC 415.8M
- IPO Year
- GILT 1993
- RNAC 2016
- Fundamental
- Price
- GILT $6.28
- RNAC $12.49
- Analyst Decision
- GILT Strong Buy
- RNAC Strong Buy
- Analyst Count
- GILT 2
- RNAC 8
- Target Price
- GILT $8.50
- RNAC $40.83
- AVG Volume (30 Days)
- GILT 325.6K
- RNAC 91.2K
- Earning Date
- GILT 05-07-2025
- RNAC 05-07-2025
- Dividend Yield
- GILT N/A
- RNAC N/A
- EPS Growth
- GILT 6.30
- RNAC N/A
- EPS
- GILT 0.44
- RNAC N/A
- Revenue
- GILT $305,448,000.00
- RNAC $38,913,000.00
- Revenue This Year
- GILT $45.38
- RNAC N/A
- Revenue Next Year
- GILT $11.84
- RNAC $60.00
- P/E Ratio
- GILT $14.57
- RNAC N/A
- Revenue Growth
- GILT 14.79
- RNAC 49.64
- 52 Week Low
- GILT $4.04
- RNAC $11.67
- 52 Week High
- GILT $8.05
- RNAC $41.87
- Technical
- Relative Strength Index (RSI)
- GILT 36.24
- RNAC 24.73
- Support Level
- GILT $6.18
- RNAC $13.57
- Resistance Level
- GILT $6.85
- RNAC $15.10
- Average True Range (ATR)
- GILT 0.20
- RNAC 1.21
- MACD
- GILT -0.06
- RNAC -0.27
- Stochastic Oscillator
- GILT 9.90
- RNAC 3.14
About GILT Gilat Satellite Networks Ltd.
Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs) and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.